Single-molecule microfluidic assay for prostate-specific antigen based on magnetic beads and upconversion nanoparticles

Sklenarova, Dorota and Hlavacek, Antonin and Krivankova, Jana and Brandmeier, Julian C. and Weisova, Julie and Rihacek, Michal and Gorris, Hans H. and Skladal, Petr and Farka, Zdenek (2024) Single-molecule microfluidic assay for prostate-specific antigen based on magnetic beads and upconversion nanoparticles. LAB ON A CHIP, 24 (14). pp. 3536-3545. ISSN 1473-0197, 1473-0189

Full text not available from this repository. (Request a copy)

Abstract

Early-stage diagnosis of prostatic carcinoma is essential for successful treatment and, thus, significant prognosis improvement. In laboratory practice, the standard non-invasive diagnostic approach is the immunochemical detection of the associated biomarker, prostate-specific antigen (PSA). Ultrasensitive detection of PSA is essential for both diagnostic and recurrence monitoring purposes. To achieve exceptional sensitivity, we have developed a microfluidic device with a flow-through cell for single-molecule analysis using photon-upconversion nanoparticles (UCNPs) as a detection label. For this purpose, magnetic microparticles (MBs) were first optimized for the capture and preconcentration of PSA and then used to implement a bead-based upconversion-linked immunoassay (ULISA) in the microfluidic device. The digital readout based on counting single nanoparticle-labeled PSA molecules on MBs enabled a detection limit of 1.04 pg mL-1 (36 fM) in 50% fetal bovine serum, which is an 11-fold improvement over the respective analog MB-based ULISA. The microfluidic technique conferred several other advantages, such as easy implementation and the potential for achieving high-throughput analysis. Finally, it was proven that the microfluidic setup is suitable for clinical sample analysis, showing a good correlation with a reference electrochemiluminescence assay (recovery rates between 97% and 105%). A microfluidic device for single-molecule detection of prostate-specific antigen was developed, utilizing magnetic microparticles as a solid phase and photon-upconversion nanoparticles as a label.

Item Type: Article
Uncontrolled Keywords: IMMUNOASSAY; FUTURE;
Subjects: 500 Science > 540 Chemistry & allied sciences
Divisions: Chemistry and Pharmacy > Institut für Analytische Chemie, Chemo- und Biosensorik
Depositing User: Dr. Gernot Deinzer
Date Deposited: 11 Nov 2025 10:47
Last Modified: 11 Nov 2025 10:47
URI: https://pred.uni-regensburg.de/id/eprint/65005

Actions (login required)

View Item View Item